Top Markets
#1 Akedo Akedo +12.06%
#2 MarsCoin MarsCoin +11.66%
#3 EXOD EXOD +9.04%
#4 Solstice Solstice +8.28%
#5 ETHGas ETHGas +7.54%
#6 龙虾 (Lobster) 龙虾 (Lobster) +6.80%
#7 Seeker Seeker +5.97%
#8 DexNet DexNet +5.76%
#9 peaq peaq +5.53%
#10 Official Trump Official Trump +5.49%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Qingdao Baheal Medical Inc. Qingdao Baheal Medical Inc.

Qingdao Baheal Medical Inc.

301015
Clasificación en acciones #6660
Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao,... Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao, China, operates as a pharmaceutical company. The firm's activities encompass the entire spectrum of drug development, from initial research to manufacturing and sales of various medicinal products. A key offering in its portfolio is vitamin D calcium in chewable tablet form.
Precio por acción
$3.69
Capitalización bursátil
$1.94B
Cambio (1 día)
3.37%
Cambio (1 año)
6.43%
País
CN
Comercio Qingdao Baheal Medical Inc. (301015)

Categoría

Healthcare
Ratio P/B de Qingdao Baheal Medical Inc. (301015)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Qingdao Baheal Medical Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Qingdao Baheal Medical Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 31.0864 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.4766 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -74.4354 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.008 -
US